8 results match your criteria: "the Institute for Scientific Analysis[Affiliation]"
J Psychoactive Drugs
January 2025
Center for Critical Public Health, The Institute for Scientific Analysis, Alameda, CA, USA.
This mixed-methods study investigated the role of medicinal cannabis use among younger adults who live in rural communities and experience high levels of cumulative social disadvantage (CSD). Results are based on cross-sectional surveys and online interviews with 153 younger adults (18-35-years old) in rural California. We assessed participants' levels of CSD (high, medium, and low) and examined associations with perceived general physical and mental health and with medicinal use of cannabis (MUC).
View Article and Find Full Text PDFNicotine Tob Res
November 2024
Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA USA.
Alcohol Clin Exp Res (Hoboken)
December 2024
The Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, Camperdown, New South Wales, Australia.
Background: Prior research has shown that early alcohol experiences, such as age of initiation and speed of progression between drinking milestones, vary across racial/ethnic groups. To inform culturally tailored prevention efforts, this longitudinal study examined racial/ethnic differences in the associations of drinking firsts at home and with parental knowledge with alcohol use outcomes among underage youth.
Methods: The study included baseline and five follow-up surveys, collected every 6 months, from California adolescents (ages 12-16 years at baseline).
Nicotine Tob Res
May 2023
Center for Critical Public Health, @ the Institute for Scientific Analysis, 1150 Ballena Blvd. Suite 211, Alameda, CA 94501, USA.
Introduction: Cigarette smoking is among the most harmful ways to consume nicotine and tends to be concentrated among socially marginalized groups of people, including sexual and gender minorities (SGM). Though some approaches to tobacco control in the United States are harm reduction strategies (eg, smoke-free environments), often abstinence is an explicitly stated goal and discussions of tobacco harm reduction (THR) are controversial, particularly for young people. Despite this controversy in the tobacco field, emerging research suggests that THR may be gaining momentum as a "community-led" rather than "public health-led" health practice.
View Article and Find Full Text PDFDrugs (Abingdon Engl)
April 2022
Center for Critical Public Health @ the Institute for Scientific Analysis, 1150 Ballena Blvd, Suite 211 Alameda, CA USA 94501.
We investigated the perceived impact of COVID-19 on changes in tobacco and nicotine (NT) use among sexual and gender minority (SGM) young adults. We used a mixed methods approach that included closed- and open-ended survey questions and in-depth interviews. Participants were 53 SGM young adults in California who reported current or past cigarette smoking.
View Article and Find Full Text PDFInt J Environ Res Public Health
May 2021
Center for Critical Public Health, the Institute for Scientific Analysis, Alameda, CA 94501, USA.
The controversy of tobacco harm reduction in the United States persists despite evidence that an important audience of tobacco prevention and control, i.e., the people who use or are likely to use nicotine and tobacco products, are engaging in practices that may be considered harm reduction.
View Article and Find Full Text PDFAm J Public Health
October 2017
Hans Oh is with the University of Southern California, School of Social Work, Los Angeles. Jordan DeVylder is with Fordham University, Graduate School of Social Service, New York, NY. Geoffrey Hunt is with the Centre for Alcohol and Drug Research, Aarhus University, Aarhus, Denmark, and the Institute for Scientific Analysis, San Francisco, CA.
Am J Public Health
December 2015
Tamar M. J. Antin is with the Prevention Research Center of the Pacific Institute for Research and Evaluation, Oakland, CA, and the Institute for Scientific Analysis, Alameda, CA. Sharon Lipperman-Kreda is with the Prevention Research Center of the Pacific Institute for Research and Evaluation. Geoffrey Hunt is with the Institute for Scientific Analysis, Alameda.
Although the population-level success of tobacco denormalization is widely accepted, it remains unclear whether these strategies alleviate health inequities for sexual and gender minorities. The high risk of smoking among sexual and gender minorities together with research that documents a relationship between stigma-related processes and smoking prevalence for these groups raises questions about whether tobacco-related stigma intensifies the disadvantages associated with the stigmas of other social identities. We have not adequately considered how tobacco-related stigma overlaps with other social identity stigmas.
View Article and Find Full Text PDF